A controlled release preparation of carbidopa/levodopa formulated to release a lower, smoother dose of medication. It is sometimes taken last thing at night in order to maintain dopamine levels throughout sleep and into the morning.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 1 |
|
1 |
Mouse over the table for more information
| 5 x 50 mg-200 mg daily | ||
|---|---|---|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Other
|
1 | 100% |
|
See all 1 patient who’ve stopped taking Carbidopa-Levodopa CR
Stopped Taking Carbidopa-Levodopa CR
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.